Most providers follow the standard titration: 0.25 mg for 4 weeks, 0.5 mg for 4 weeks, 1.0 mg for 4 weeks, 1.7 mg for 4 weeks, and 2.4 mg as the target maintenance dose
More broadly, their habits and decisions will drive how product innovation happens and how the food supply chain is impacted
We strive to optimize the benefits of GLP-1 medications, including their potential cardiovascular advantages, to enhance the overall well-being of our patients
The remaining 35 states (Alabama, Alaska, Arkansas, Colorado, Connecticut, Delaware, Hawaii, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Utah, Vermont, West Virginia, Wisconsin, Wyoming) follow their state PDL more closely with fewer MCO carve-outs